Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Could administration of bacille Calmette‐Guérin vaccination at birth protect from the development of asthma and allergic diseases in the western world? Has this question been adequately investigated?

Could administration of bacille Calmette‐Guérin vaccination at birth protect from the development... Asthma and allergic diseases are disorders with a predominant Th2 immune response and there is some evidence of an inverse correlation between incidence of tuberculosis and prevalence of allergic diseases. Skewing the immune response towards a Th1 phenotype has been shown to suppress allergic inflammation. One of the ways this could be achieved is by administration of BCG vaccination early in life. Unfortunately, studies examining the protective role of BCG vaccination early in life against development of allergic diseases have shown some conflicting results and this article critically discusses the pitfalls in the currently available data. We propose that well controlled double blind placebo‐controlled multi‐centre study is carried out to address this important question and if this study shows a favourable outcome simple measures such as offering BCG vaccination early in life could help reduceprevalence of allergic diseases. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Pediatric Allergy and Immunology Wiley

Could administration of bacille Calmette‐Guérin vaccination at birth protect from the development of asthma and allergic diseases in the western world? Has this question been adequately investigated?

Loading next page...
 
/lp/wiley/could-administration-of-bacille-calmette-gu-rin-vaccination-at-birth-cF9vfslNvq

References (50)

Publisher
Wiley
Copyright
Copyright © 2002 Wiley Subscription Services, Inc., A Wiley Company
ISSN
0905-6157
eISSN
1399-3038
DOI
10.1034/j.1399-3038.2002.01048.x
Publisher site
See Article on Publisher Site

Abstract

Asthma and allergic diseases are disorders with a predominant Th2 immune response and there is some evidence of an inverse correlation between incidence of tuberculosis and prevalence of allergic diseases. Skewing the immune response towards a Th1 phenotype has been shown to suppress allergic inflammation. One of the ways this could be achieved is by administration of BCG vaccination early in life. Unfortunately, studies examining the protective role of BCG vaccination early in life against development of allergic diseases have shown some conflicting results and this article critically discusses the pitfalls in the currently available data. We propose that well controlled double blind placebo‐controlled multi‐centre study is carried out to address this important question and if this study shows a favourable outcome simple measures such as offering BCG vaccination early in life could help reduceprevalence of allergic diseases.

Journal

Pediatric Allergy and ImmunologyWiley

Published: Jun 1, 2002

There are no references for this article.